Trial intelligence / Profile preview

Abrupt vs Tapered Discontinuation of Postmenopausal Hormone Therapy

NCT04050592Phase 4Unknown

Start
Feb 2020
Primary completion
Dec 2022
Modality
Hormone, Biologic
Countries
1
01

Overview

A Phase 4 trial of estradiol in menopause. Status: unknown.

02

Drugs

estradiol
03

Conditions

menopause

Beyond the preview

Go deeper on NCT04050592.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04050592.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call